Boston
With numerous prestigious academic institutions in the region, Boston is home to some of the most innovative minds in the world, making it a strong market for emerging and growth oriented companies and the venture capital and growth equity funds that back them. In the first half of 2022 alone, companies within the region raised over $18 billion in venture capital.
Our Boston office has grown with the region’s innovation economy. In just over two decades, we have expanded to more than 70 attorneys representing nearly 650 companies across ground-breaking industries including life sciences (biotech, diagnostics, medical devices, etc.), healthcare services, data storage, networking, robotics, productivity/software, artificial intelligence/machine learning, blockchain, energy and fintech. In addition, over 200 venture capital and growth equity firms trust our Boston attorneys to support their legal needs — from fund formation and fundraising to day-to-day operational matters and portfolio investing. We tailor our services to forward-thinking private technology and life sciences companies and the venture capital and growth equity firms that invest in them, serving as advisors through inception, growth and maturity.
We help our clients meet and overcome the unique challenges facing high-growth companies and venture capital and growth equity funds that seek to change the world in their respective fields. Since 2020, the Boston team closed more than 1,500 debt and equity financings totaling over $50 billion for our company and fund clients, formed hundreds of new venture capital and growth equity funds, bought and sold dozens of companies, handled numerous licensing and other strategic transactions, supported IPOs and other public offerings, and addressed the executive compensation and employment needs of our clients.
Our team has preeminent experience in what are the most important strategic needs of high-growth companies, venture capital and growth equity funds.
Office Leaders
